Mineralys Therapeutics, Inc.
MLYS
11 insider filings · Latest: May 18, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | May 19 7:15 PM | David Malcom RodmanChief Medical Officer | Sale | 417 | $27.55 | $11.5K | 63,443(D) | View → |
| May 13, 2026 | May 13 9:42 PM | David Malcom RodmanChief Medical Officer | Sale | 14,056 | $28.58 | $401.8K | 63,443(D) | View → |
| May 12, 2026 | May 13 9:42 PM | David Malcom RodmanChief Medical Officer | Sale | 6,348 | $29.36 | $186.3K | 69,792(D) | View → |
| May 11, 2026 | May 13 9:42 PM | David Malcom RodmanChief Medical Officer | Sale | 2,171 | $29.71 | $64.5K | 69,792(D) | View → |
| Apr 17, 2026 | Apr 21 6:59 PM | David Malcom RodmanChief Medical Officer | Sale | 416 | $31.33 | $13.0K | 69,792(D) | View → |
| Apr 15, 2026 | Apr 15 9:45 PM | David Malcom RodmanChief Medical Officer | Sale | 6,348 | $27.66 | $175.6K | 69,792(D) | View → |
| Apr 13, 2026 | Apr 15 9:45 PM | David Malcom RodmanChief Medical Officer | Sale | 14,058 | $26.54 | $373.1K | 76,140(D) | View → |
| Apr 13, 2026 | Apr 15 9:45 PM | Jon CongletonDirector, Chief Executive Officer | Sale | 15,730 | $26.83 | $422.0K | 689,321(D) | View → |
| Apr 9, 2026 | Apr 13 9:13 PM | David Malcom RodmanChief Medical Officer | Sale | 2,170 | $27.38 | $59.4K | 76,140(D) | View → |
| Mar 31, 2026 | Apr 2 6:54 PM | Jon CongletonDirector, Chief Executive Officer | Sale | 75,000 | $26.27 | $2.0M | 705,051(D) | View → |
| Mar 31, 2026 | Apr 2 6:53 PM | Daphne KarydasDirector | Sale | 3,000 | $25.00 | $75.0K | 6,200(D) | View → |
| Mar 30, 2026 | Mar 31 4:15 PM | RA CAPITAL MANAGEMENT, L.P.Director | Purchase | 58,300 | $24.16 | $1.4M | 5,825,521(I) | View → |
| Mar 27, 2026 | Mar 31 4:15 PM | RA CAPITAL MANAGEMENT, L.P.Director | Purchase | 310,700 | $23.67 | $7.4M | 5,767,221(I) | View → |
| Mar 17, 2026 | Mar 17 4:51 PM | David Malcom RodmanChief Medical Officer | Sale | 417 | $25.65 | $10.7K | 76,140(D) | View → |
| Mar 13, 2026 | Mar 16 5:20 PM | David Malcom RodmanChief Medical Officer | Sale | 14,058 | $26.26 | $369.2K | 76,140(D) | View → |
| Mar 12, 2026 | Mar 16 5:20 PM | David Malcom RodmanChief Medical Officer | Sale | 6,348 | $27.37 | $173.7K | 82,489(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 18, 2026 | May 19 7:15 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 417 | $15.44 | 4,167(D) | View → |
| May 13, 2026 | May 13 9:42 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 7,707 | $14.25 | 87,501(D) | View → |
| May 12, 2026 | May 13 9:42 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 6,348 | $1.08 | 12,698(D) | View → |
| May 11, 2026 | May 13 9:42 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 2,171 | $16.00 | 19,535(D) | View → |
| Apr 17, 2026 | Apr 21 6:59 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 416 | $15.44 | 4,584(D) | View → |
| Apr 13, 2026 | Apr 15 9:45 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 14,058 | $14.25 | 91,667(D) | View → |
| Apr 9, 2026 | Apr 13 9:13 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 2,170 | $16.00 | 21,706(D) | View → |
| Mar 31, 2026 | Apr 2 6:53 PM | Daphne KarydasDirector | Option Exercise | 3,000 | $12.02 | 41,000(D) | View → |
| Mar 17, 2026 | Mar 17 4:51 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 417 | $15.44 | 5,000(D) | View → |
| Mar 13, 2026 | Mar 16 5:20 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 7,709 | $14.25 | 95,834(D) | View → |
| Mar 12, 2026 | Mar 16 5:20 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 6,348 | $1.08 | 25,395(D) | View → |